Stock Events

Stock Events

Moberg Pharma AB 

€0.9
10
+€0.01+0.9% Today

Statistics

Day High
0.9
Day Low
0.9
52W High
1.03
52W Low
0.57
Volume
-
Avg. Volume
-
Mkt Cap
43.6M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.01
-0.01
-0
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-179.01%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.54MRevenue
-6.34MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MB8.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of healthcare products that compete with Moberg Pharma's offerings.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global biopharmaceutical company with a portfolio that includes treatments in areas similar to those targeted by Moberg Pharma.
Novartis
NVS
Mkt Cap237.61B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same categories as Moberg Pharma.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a healthcare company that develops and markets drugs and vaccines in various areas, including those competing with Moberg Pharma.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that offers products in areas that overlap with Moberg Pharma's therapeutic focus.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company with a broad range of medical products that compete in the same market as Moberg Pharma.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global healthcare leader that offers drugs in many of the same therapeutic areas as Moberg Pharma.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company focused on developing novel treatments, some of which compete with Moberg Pharma's products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly in some of the markets targeted by Moberg Pharma.

About

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.
Show more...
CEO
ISIN
SE0020353928
WKN
000A3EGXK

Listings

F
DE
MB8.F
ST
SE
MOB.ST
OTC Link
US
MBGPF

0 Comments

Share your thoughts

FAQ

What is Moberg Pharma AB stock price today?▼
The current price of MB8.F is €0.9 EUR — it has increased by +0.9% in the past 24 hours. Watch Moberg Pharma AB stock price performance more closely on the chart.
What is Moberg Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Moberg Pharma AB stocks are traded under the ticker MB8.F.
Is Moberg Pharma AB stock price growing?▼
MB8.F stock has risen by +2.05% compared to the previous week, the month change is a +0.67% rise, over the last year Moberg Pharma AB has showed a +32.79% increase.
What is Moberg Pharma AB market cap?▼
Today Moberg Pharma AB has the market capitalization of 43.6M
When is the next Moberg Pharma AB earnings date?▼
Moberg Pharma AB is going to release the next earnings report on May 12, 2026.
What is Moberg Pharma AB revenue for the last year?▼
Moberg Pharma AB revenue for the last year amounts to 3.54M EUR.
What is Moberg Pharma AB net income for the last year?▼
MB8.F net income for the last year is -6.34M EUR.
When did Moberg Pharma AB complete a stock split?▼
The last stock split for Moberg Pharma AB was on May 24, 2023 with a ratio of 1:10.